Jaspreet advises market-leading tech and healthcare companies on issues at the cutting-edge of digital health.
She focuses on the development and regulation of healthcare technology and data solutions. This includes assessing how digital health solutions can comply with the legal framework for data privacy, medical research and medical devices / pharmaceuticals.
Jaspreet advises clients on complex issues at the intersection of healthcare, data and technology. Her practice has a particular focus on accessing and using patient data, innovative collaborations with hospitals, and the use and regulation of AI in the healthcare space.
Jaspreet regularly speaks at medtech and pharma industry trade association events on issues ranging from health data and innovation to medical research. She has contributed to white papers and policy work by the Association of the British HealthTech Industry (ABHI) and the UK’s Department of Health and Social Care, focussing on the future regulation of health data and fostering healthtech innovation in the UK.
Representative Legal Matters
Advising a tech company on use of medical datasets from academic and medical institutions across the globe, for the purposes of validating an AI product in a wider patient population.
Advising a consultancy firm on the application of medical device legislation to an AI algorithm capable of providing diagnostic support to clinicians assessing mammograms.
Supporting a medtech company in collaborating with an NHS trust to set up a new lab providing diagnostic services to other UK hospitals.
Supporting a medtech company in contracting with NHS trusts and private hospitals across the UK for the supply of robotic surgical equipment, software and related consumables.
Advising various pharmaceutical companies, medtech companies and tech companies on the use of patient data and the data of healthcare professionals for a range of purposes, including for the development of healthcare technologies, for direct marketing and for the provision of NHS-commissioned services.
Supporting a pharmaceutical company on the launch of an app for patients and related publicity.
Advising various providers of clinical trial support services on the regulatory hurdles in rolling out decentralised clinical trials across the globe, including remote monitoring of patients, home delivery of IMPs and deploying nurses for home visits (including data privacy issues, clinical trial regulation and staffing models).
Advising on a research collaboration for the establishment of a patient registry for a rare disease, including advising on the related research collaboration agreement and data privacy issues.
- England & Wales~United Kingdom (2015)
- College of Law (Legal Practice Course Distinction) (2012)
- King's College London (LLB (Hons) Law with European Legal Studies), (First Class) (2011)
- Co-author, "United Kingdom: An open letter to policymakers - We need to talk about the real issue with health data regulation," InsightPlus, March 2021
- Presenter, "GDPR in the life sciences industry’ to the students on Charles University’s Pharma and Medical Devices Course," March 2021
- Author, "What’s next for health data in 2021?," Life Sciences Lawyer Magazine, Issue 1 2021
- Contributor, "White Paper: Digital Health Regulatory Concepts," Association of British HealthTech (ABHI), May 2021
- Author, "What are the essential items to have on your radar if advising an organisation that accesses or uses NHS data?," Q&A published on Lexis®PSL, February 2021